See every side of every news story
Published loading...Updated

Oz to pitch GOP senators on need for Medicaid changes

  • Mehmet Oz recently assumed leadership of CMS, where he will manage Medicare drug-price talks established under the 2022 Inflation Reduction Act aimed at lowering prescription costs.
  • These negotiations apply within Medicare Part D but allow insurers to place negotiated drugs on higher-cost tiers and restrict access.
  • Independent pharmacies face financial risks including delayed reimbursements and margin cuts, causing 93 percent to consider not stocking some negotiated drugs.
  • Among the 15 drugs recently chosen for Medicare price-setting are a pair of asthma treatments, raising concerns about patient access as one in six individuals with asthma faces difficulties affording their medications.
  • If CMS and Congress do not intervene to address formulary manipulation and payment issues, drug pricing changes intended to help patients may inadvertently increase expenses, reduce availability, and negatively impact those in need.
Insights by Ground AI
Does this summary seem wrong?

6 Articles

All
Left
1
Center
3
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Hill broke the news in Washington, United States on Tuesday, June 17, 2025.
Sources are mostly out of (0)